nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—Vismodegib—Sulfasalazine—Crohn's disease	0.445	1	CrCrCtD
Etoricoxib—PTGS2—Crohn's disease	0.172	1	CbGaD
Etoricoxib—PTGS2—Balsalazide—Crohn's disease	0.105	0.406	CbGbCtD
Etoricoxib—PTGS2—Mesalazine—Crohn's disease	0.0837	0.325	CbGbCtD
Etoricoxib—PTGS2—Sulfasalazine—Crohn's disease	0.0468	0.181	CbGbCtD
Etoricoxib—CYP2C19—Prednisone—Crohn's disease	0.0153	0.0593	CbGbCtD
Etoricoxib—CYP3A4—Prednisone—Crohn's disease	0.00739	0.0287	CbGbCtD
Etoricoxib—MAPK14—mouth—Crohn's disease	0.00112	0.16	CbGeAlD
Etoricoxib—Vemurafenib—ALB—Crohn's disease	0.000695	0.364	CrCbGaD
Etoricoxib—MAPK14—epithelium—Crohn's disease	0.000654	0.093	CbGeAlD
Etoricoxib—MAPK14—smooth muscle tissue—Crohn's disease	0.00063	0.0897	CbGeAlD
Etoricoxib—MAPK14—skin of body—Crohn's disease	0.000622	0.0885	CbGeAlD
Etoricoxib—MAPK14—lymphoid tissue—Crohn's disease	0.000504	0.0717	CbGeAlD
Etoricoxib—MAPK14—digestive system—Crohn's disease	0.000498	0.0708	CbGeAlD
Etoricoxib—Celecoxib—PTGS2—Crohn's disease	0.000458	0.24	CrCbGaD
Etoricoxib—Gamma-glutamyltransferase increased—Mesalazine—Crohn's disease	0.000448	0.00641	CcSEcCtD
Etoricoxib—Breast disorder—Mercaptopurine—Crohn's disease	0.000446	0.00638	CcSEcCtD
Etoricoxib—Proteinuria—Mesalazine—Crohn's disease	0.00042	0.00601	CcSEcCtD
Etoricoxib—Pancreatitis—Mercaptopurine—Crohn's disease	0.000418	0.00598	CcSEcCtD
Etoricoxib—Protein urine present—Mesalazine—Crohn's disease	0.000414	0.00592	CcSEcCtD
Etoricoxib—Trauma—Prednisone—Crohn's disease	0.00041	0.00586	CcSEcCtD
Etoricoxib—Celecoxib—ALB—Crohn's disease	0.000409	0.214	CrCbGaD
Etoricoxib—Neck pain—Mesalazine—Crohn's disease	0.000373	0.00534	CcSEcCtD
Etoricoxib—Musculoskeletal pain—Mesalazine—Crohn's disease	0.000373	0.00534	CcSEcCtD
Etoricoxib—Epigastric discomfort—Prednisone—Crohn's disease	0.000371	0.00531	CcSEcCtD
Etoricoxib—Stomatitis—Mercaptopurine—Crohn's disease	0.00037	0.0053	CcSEcCtD
Etoricoxib—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.000369	0.00528	CcSEcCtD
Etoricoxib—Neoplasm—Azathioprine—Crohn's disease	0.000366	0.00524	CcSEcCtD
Etoricoxib—PTGS2—gall bladder—Crohn's disease	0.000364	0.0517	CbGeAlD
Etoricoxib—Cystitis noninfective—Mesalazine—Crohn's disease	0.00036	0.00515	CcSEcCtD
Etoricoxib—Melaena—Mesalazine—Crohn's disease	0.00036	0.00515	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.000359	0.00514	CcSEcCtD
Etoricoxib—Cystitis—Mesalazine—Crohn's disease	0.000356	0.0051	CcSEcCtD
Etoricoxib—Vismodegib—ALB—Crohn's disease	0.00035	0.183	CrCbGaD
Etoricoxib—Vaginal infection—Mesalazine—Crohn's disease	0.000348	0.00498	CcSEcCtD
Etoricoxib—Blood urea increased—Mesalazine—Crohn's disease	0.000348	0.00498	CcSEcCtD
Etoricoxib—Neuropathy—Mesalazine—Crohn's disease	0.000346	0.00495	CcSEcCtD
Etoricoxib—Mouth ulceration—Mesalazine—Crohn's disease	0.000333	0.00477	CcSEcCtD
Etoricoxib—Bladder pain—Mesalazine—Crohn's disease	0.000333	0.00477	CcSEcCtD
Etoricoxib—Ecchymosis—Mesalazine—Crohn's disease	0.000333	0.00477	CcSEcCtD
Etoricoxib—Hepatic failure—Azathioprine—Crohn's disease	0.000327	0.00468	CcSEcCtD
Etoricoxib—PTGS2—mouth—Crohn's disease	0.000323	0.046	CbGeAlD
Etoricoxib—Immune system disorder—Mercaptopurine—Crohn's disease	0.000308	0.00441	CcSEcCtD
Etoricoxib—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.000308	0.0044	CcSEcCtD
Etoricoxib—Gastroenteritis—Mesalazine—Crohn's disease	0.000302	0.00432	CcSEcCtD
Etoricoxib—Alopecia—Mercaptopurine—Crohn's disease	0.000301	0.00431	CcSEcCtD
Etoricoxib—Eczema—Mesalazine—Crohn's disease	0.000298	0.00426	CcSEcCtD
Etoricoxib—Hepatic failure—Mesalazine—Crohn's disease	0.000298	0.00426	CcSEcCtD
Etoricoxib—Malnutrition—Mercaptopurine—Crohn's disease	0.000297	0.00425	CcSEcCtD
Etoricoxib—Peptic ulcer—Prednisone—Crohn's disease	0.000292	0.00418	CcSEcCtD
Etoricoxib—MAPK14—lymph node—Crohn's disease	0.000284	0.0404	CbGeAlD
Etoricoxib—Atrial fibrillation—Mesalazine—Crohn's disease	0.000282	0.00404	CcSEcCtD
Etoricoxib—Renal impairment—Mesalazine—Crohn's disease	0.000281	0.00403	CcSEcCtD
Etoricoxib—Thirst—Mesalazine—Crohn's disease	0.000281	0.00403	CcSEcCtD
Etoricoxib—Anaemia—Mercaptopurine—Crohn's disease	0.000274	0.00393	CcSEcCtD
Etoricoxib—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.000268	0.00383	CcSEcCtD
Etoricoxib—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.000265	0.00379	CcSEcCtD
Etoricoxib—Arthralgia—Mercaptopurine—Crohn's disease	0.000253	0.00362	CcSEcCtD
Etoricoxib—Fungal infection—Prednisone—Crohn's disease	0.000253	0.00362	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000251	0.00359	CcSEcCtD
Etoricoxib—Blood creatinine increased—Mesalazine—Crohn's disease	0.000251	0.00359	CcSEcCtD
Etoricoxib—Pancreatitis—Azathioprine—Crohn's disease	0.000249	0.00356	CcSEcCtD
Etoricoxib—Memory impairment—Prednisone—Crohn's disease	0.000249	0.00356	CcSEcCtD
Etoricoxib—Orthostatic hypotension—Mesalazine—Crohn's disease	0.000244	0.0035	CcSEcCtD
Etoricoxib—Abdominal discomfort—Azathioprine—Crohn's disease	0.000243	0.00348	CcSEcCtD
Etoricoxib—Oedema—Mercaptopurine—Crohn's disease	0.000242	0.00347	CcSEcCtD
Etoricoxib—Breast disorder—Mesalazine—Crohn's disease	0.000242	0.00346	CcSEcCtD
Etoricoxib—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.000241	0.00345	CcSEcCtD
Etoricoxib—Cramp muscle—Mesalazine—Crohn's disease	0.000241	0.00345	CcSEcCtD
Etoricoxib—Glycosuria—Prednisone—Crohn's disease	0.000241	0.00345	CcSEcCtD
Etoricoxib—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000237	0.0034	CcSEcCtD
Etoricoxib—Gastritis—Mesalazine—Crohn's disease	0.000237	0.00339	CcSEcCtD
Etoricoxib—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.000236	0.00338	CcSEcCtD
Etoricoxib—Skin disorder—Mercaptopurine—Crohn's disease	0.000235	0.00337	CcSEcCtD
Etoricoxib—Abdominal distension—Mesalazine—Crohn's disease	0.000233	0.00333	CcSEcCtD
Etoricoxib—Anorexia—Mercaptopurine—Crohn's disease	0.000231	0.00331	CcSEcCtD
Etoricoxib—Pneumonia—Azathioprine—Crohn's disease	0.000228	0.00326	CcSEcCtD
Etoricoxib—Bronchospasm—Mesalazine—Crohn's disease	0.000228	0.00326	CcSEcCtD
Etoricoxib—Pancreatitis—Mesalazine—Crohn's disease	0.000227	0.00325	CcSEcCtD
Etoricoxib—Infestation—Azathioprine—Crohn's disease	0.000226	0.00324	CcSEcCtD
Etoricoxib—Infestation NOS—Azathioprine—Crohn's disease	0.000226	0.00324	CcSEcCtD
Etoricoxib—Angina pectoris—Mesalazine—Crohn's disease	0.000225	0.00323	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000224	0.00321	CcSEcCtD
Etoricoxib—Contusion—Prednisone—Crohn's disease	0.000224	0.0032	CcSEcCtD
Etoricoxib—Bronchitis—Mesalazine—Crohn's disease	0.000222	0.00318	CcSEcCtD
Etoricoxib—Abdominal discomfort—Mesalazine—Crohn's disease	0.000222	0.00317	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000221	0.00316	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000215	0.00308	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000214	0.00307	CcSEcCtD
Etoricoxib—CYP2C19—digestive system—Crohn's disease	0.000212	0.0301	CbGeAlD
Etoricoxib—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000211	0.00302	CcSEcCtD
Etoricoxib—Decreased appetite—Mercaptopurine—Crohn's disease	0.000211	0.00302	CcSEcCtD
Etoricoxib—Weight increased—Mesalazine—Crohn's disease	0.000211	0.00301	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000209	0.00299	CcSEcCtD
Etoricoxib—Pneumonia—Mesalazine—Crohn's disease	0.000207	0.00297	CcSEcCtD
Etoricoxib—Infestation NOS—Mesalazine—Crohn's disease	0.000206	0.00295	CcSEcCtD
Etoricoxib—Infestation—Mesalazine—Crohn's disease	0.000206	0.00295	CcSEcCtD
Etoricoxib—Cataract—Prednisone—Crohn's disease	0.000205	0.00293	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000204	0.00293	CcSEcCtD
Etoricoxib—Haemoglobin—Azathioprine—Crohn's disease	0.000204	0.00292	CcSEcCtD
Etoricoxib—Haemorrhage—Azathioprine—Crohn's disease	0.000203	0.00291	CcSEcCtD
Etoricoxib—Renal failure—Mesalazine—Crohn's disease	0.000203	0.0029	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000202	0.00289	CcSEcCtD
Etoricoxib—Stomatitis—Mesalazine—Crohn's disease	0.000201	0.00288	CcSEcCtD
Etoricoxib—Jaundice—Mesalazine—Crohn's disease	0.000201	0.00288	CcSEcCtD
Etoricoxib—Urinary tract infection—Mesalazine—Crohn's disease	0.0002	0.00287	CcSEcCtD
Etoricoxib—Conjunctivitis—Mesalazine—Crohn's disease	0.0002	0.00287	CcSEcCtD
Etoricoxib—Haematuria—Mesalazine—Crohn's disease	0.000197	0.00281	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000195	0.00279	CcSEcCtD
Etoricoxib—Epistaxis—Mesalazine—Crohn's disease	0.000195	0.00278	CcSEcCtD
Etoricoxib—Sinusitis—Mesalazine—Crohn's disease	0.000194	0.00277	CcSEcCtD
Etoricoxib—Erythema multiforme—Azathioprine—Crohn's disease	0.000192	0.00275	CcSEcCtD
Etoricoxib—PTGS2—epithelium—Crohn's disease	0.000188	0.0268	CbGeAlD
Etoricoxib—Haemoglobin—Mesalazine—Crohn's disease	0.000186	0.00266	CcSEcCtD
Etoricoxib—Hepatitis—Mesalazine—Crohn's disease	0.000185	0.00265	CcSEcCtD
Etoricoxib—Haemorrhage—Mesalazine—Crohn's disease	0.000185	0.00265	CcSEcCtD
Etoricoxib—Pharyngitis—Mesalazine—Crohn's disease	0.000184	0.00263	CcSEcCtD
Etoricoxib—Immune system disorder—Azathioprine—Crohn's disease	0.000184	0.00263	CcSEcCtD
Etoricoxib—Mediastinal disorder—Azathioprine—Crohn's disease	0.000183	0.00262	CcSEcCtD
Etoricoxib—Neuropathy—Prednisone—Crohn's disease	0.000183	0.00262	CcSEcCtD
Etoricoxib—Urinary tract disorder—Mesalazine—Crohn's disease	0.000183	0.00262	CcSEcCtD
Etoricoxib—Oedema peripheral—Mesalazine—Crohn's disease	0.000182	0.00261	CcSEcCtD
Etoricoxib—Connective tissue disorder—Mesalazine—Crohn's disease	0.000182	0.0026	CcSEcCtD
Etoricoxib—Arrhythmia—Azathioprine—Crohn's disease	0.000182	0.0026	CcSEcCtD
Etoricoxib—Urethral disorder—Mesalazine—Crohn's disease	0.000182	0.0026	CcSEcCtD
Etoricoxib—PTGS2—smooth muscle tissue—Crohn's disease	0.000181	0.0258	CbGeAlD
Etoricoxib—Alopecia—Azathioprine—Crohn's disease	0.00018	0.00257	CcSEcCtD
Etoricoxib—PTGS2—skin of body—Crohn's disease	0.000179	0.0254	CbGeAlD
Etoricoxib—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000179	0.00256	CcSEcCtD
Etoricoxib—Ecchymosis—Prednisone—Crohn's disease	0.000176	0.00252	CcSEcCtD
Etoricoxib—Erythema multiforme—Mesalazine—Crohn's disease	0.000175	0.00251	CcSEcCtD
Etoricoxib—Eye disorder—Mesalazine—Crohn's disease	0.000173	0.00248	CcSEcCtD
Etoricoxib—CYP1A2—digestive system—Crohn's disease	0.000173	0.0246	CbGeAlD
Etoricoxib—Tinnitus—Mesalazine—Crohn's disease	0.000173	0.00247	CcSEcCtD
Etoricoxib—Cardiac disorder—Mesalazine—Crohn's disease	0.000172	0.00246	CcSEcCtD
Etoricoxib—Angiopathy—Mesalazine—Crohn's disease	0.000168	0.0024	CcSEcCtD
Etoricoxib—Immune system disorder—Mesalazine—Crohn's disease	0.000167	0.00239	CcSEcCtD
Etoricoxib—Mediastinal disorder—Mesalazine—Crohn's disease	0.000167	0.00239	CcSEcCtD
Etoricoxib—Diarrhoea—Mercaptopurine—Crohn's disease	0.000166	0.00237	CcSEcCtD
Etoricoxib—CYP2C9—digestive system—Crohn's disease	0.000164	0.0233	CbGeAlD
Etoricoxib—Alopecia—Mesalazine—Crohn's disease	0.000164	0.00234	CcSEcCtD
Etoricoxib—Anaemia—Azathioprine—Crohn's disease	0.000164	0.00234	CcSEcCtD
Etoricoxib—Diabetes mellitus—Prednisone—Crohn's disease	0.000163	0.00233	CcSEcCtD
Etoricoxib—Mental disorder—Mesalazine—Crohn's disease	0.000162	0.00232	CcSEcCtD
Etoricoxib—Erythema—Mesalazine—Crohn's disease	0.000161	0.00231	CcSEcCtD
Etoricoxib—Flatulence—Mesalazine—Crohn's disease	0.000159	0.00227	CcSEcCtD
Etoricoxib—Dysgeusia—Mesalazine—Crohn's disease	0.000158	0.00226	CcSEcCtD
Etoricoxib—CYP2E1—lymphoid tissue—Crohn's disease	0.000157	0.0224	CbGeAlD
Etoricoxib—Cardiac failure congestive—Prednisone—Crohn's disease	0.000156	0.00223	CcSEcCtD
Etoricoxib—CYP2E1—digestive system—Crohn's disease	0.000155	0.0221	CbGeAlD
Etoricoxib—Muscle spasms—Mesalazine—Crohn's disease	0.000155	0.00222	CcSEcCtD
Etoricoxib—Vomiting—Mercaptopurine—Crohn's disease	0.000154	0.00221	CcSEcCtD
Etoricoxib—Injury—Prednisone—Crohn's disease	0.000154	0.00221	CcSEcCtD
Etoricoxib—Rash—Mercaptopurine—Crohn's disease	0.000153	0.00219	CcSEcCtD
Etoricoxib—Dermatitis—Mercaptopurine—Crohn's disease	0.000153	0.00219	CcSEcCtD
Etoricoxib—Vision blurred—Mesalazine—Crohn's disease	0.000152	0.00217	CcSEcCtD
Etoricoxib—Tremor—Mesalazine—Crohn's disease	0.000151	0.00216	CcSEcCtD
Etoricoxib—Arthralgia—Azathioprine—Crohn's disease	0.000151	0.00216	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00015	0.00214	CcSEcCtD
Etoricoxib—Anaemia—Mesalazine—Crohn's disease	0.000149	0.00213	CcSEcCtD
Etoricoxib—Angioedema—Mesalazine—Crohn's disease	0.000147	0.00211	CcSEcCtD
Etoricoxib—PTGS2—lymphoid tissue—Crohn's disease	0.000145	0.0206	CbGeAlD
Etoricoxib—Nausea—Mercaptopurine—Crohn's disease	0.000144	0.00206	CcSEcCtD
Etoricoxib—Infection—Azathioprine—Crohn's disease	0.000143	0.00205	CcSEcCtD
Etoricoxib—PTGS2—digestive system—Crohn's disease	0.000143	0.0204	CbGeAlD
Etoricoxib—Palpitations—Mesalazine—Crohn's disease	0.000142	0.00204	CcSEcCtD
Etoricoxib—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000142	0.00203	CcSEcCtD
Etoricoxib—Thrombocytopenia—Azathioprine—Crohn's disease	0.000141	0.00202	CcSEcCtD
Etoricoxib—Cough—Mesalazine—Crohn's disease	0.000141	0.00201	CcSEcCtD
Etoricoxib—Skin disorder—Azathioprine—Crohn's disease	0.00014	0.00201	CcSEcCtD
Etoricoxib—Hypertension—Mesalazine—Crohn's disease	0.000139	0.00199	CcSEcCtD
Etoricoxib—Arthralgia—Mesalazine—Crohn's disease	0.000137	0.00196	CcSEcCtD
Etoricoxib—Chest pain—Mesalazine—Crohn's disease	0.000137	0.00196	CcSEcCtD
Etoricoxib—Anxiety—Mesalazine—Crohn's disease	0.000137	0.00196	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000136	0.00195	CcSEcCtD
Etoricoxib—Cardiac arrest—Prednisone—Crohn's disease	0.000135	0.00193	CcSEcCtD
Etoricoxib—Dry mouth—Mesalazine—Crohn's disease	0.000134	0.00192	CcSEcCtD
Etoricoxib—Confusional state—Mesalazine—Crohn's disease	0.000133	0.0019	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000132	0.00188	CcSEcCtD
Etoricoxib—Anaphylactic shock—Mesalazine—Crohn's disease	0.000132	0.00188	CcSEcCtD
Etoricoxib—Oedema—Mesalazine—Crohn's disease	0.000132	0.00188	CcSEcCtD
Etoricoxib—Infection—Mesalazine—Crohn's disease	0.000131	0.00187	CcSEcCtD
Etoricoxib—Shock—Mesalazine—Crohn's disease	0.000129	0.00185	CcSEcCtD
Etoricoxib—Nervous system disorder—Mesalazine—Crohn's disease	0.000129	0.00185	CcSEcCtD
Etoricoxib—Thrombocytopenia—Mesalazine—Crohn's disease	0.000129	0.00184	CcSEcCtD
Etoricoxib—Skin disorder—Mesalazine—Crohn's disease	0.000128	0.00183	CcSEcCtD
Etoricoxib—Anorexia—Mesalazine—Crohn's disease	0.000125	0.00179	CcSEcCtD
Etoricoxib—CYP3A4—digestive system—Crohn's disease	0.000125	0.0178	CbGeAlD
Etoricoxib—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000125	0.00179	CcSEcCtD
Etoricoxib—Muscular weakness—Prednisone—Crohn's disease	0.000125	0.00179	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000125	0.00178	CcSEcCtD
Etoricoxib—Abdominal distension—Prednisone—Crohn's disease	0.000123	0.00176	CcSEcCtD
Etoricoxib—CYP2D6—digestive system—Crohn's disease	0.000123	0.0175	CbGeAlD
Etoricoxib—Pancreatitis—Prednisone—Crohn's disease	0.00012	0.00172	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00012	0.00172	CcSEcCtD
Etoricoxib—Feeling abnormal—Azathioprine—Crohn's disease	0.000119	0.0017	CcSEcCtD
Etoricoxib—Insomnia—Mesalazine—Crohn's disease	0.000119	0.0017	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000118	0.00169	CcSEcCtD
Etoricoxib—Dyspnoea—Mesalazine—Crohn's disease	0.000117	0.00168	CcSEcCtD
Etoricoxib—Somnolence—Mesalazine—Crohn's disease	0.000117	0.00167	CcSEcCtD
Etoricoxib—Dyspepsia—Mesalazine—Crohn's disease	0.000116	0.00166	CcSEcCtD
Etoricoxib—Decreased appetite—Mesalazine—Crohn's disease	0.000114	0.00164	CcSEcCtD
Etoricoxib—Abdominal pain—Azathioprine—Crohn's disease	0.000114	0.00163	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000114	0.00163	CcSEcCtD
Etoricoxib—Fatigue—Mesalazine—Crohn's disease	0.000113	0.00162	CcSEcCtD
Etoricoxib—Pain—Mesalazine—Crohn's disease	0.000112	0.00161	CcSEcCtD
Etoricoxib—Constipation—Mesalazine—Crohn's disease	0.000112	0.00161	CcSEcCtD
Etoricoxib—Weight increased—Prednisone—Crohn's disease	0.000111	0.00159	CcSEcCtD
Etoricoxib—Hyperglycaemia—Prednisone—Crohn's disease	0.00011	0.00158	CcSEcCtD
Etoricoxib—Feeling abnormal—Mesalazine—Crohn's disease	0.000108	0.00155	CcSEcCtD
Etoricoxib—Acute coronary syndrome—Prednisone—Crohn's disease	0.000108	0.00154	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000108	0.00154	CcSEcCtD
Etoricoxib—Myocardial infarction—Prednisone—Crohn's disease	0.000107	0.00153	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Prednisone—Crohn's disease	0.000107	0.00153	CcSEcCtD
Etoricoxib—Hypersensitivity—Azathioprine—Crohn's disease	0.000106	0.00152	CcSEcCtD
Etoricoxib—Urticaria—Mesalazine—Crohn's disease	0.000105	0.0015	CcSEcCtD
Etoricoxib—Abdominal pain—Mesalazine—Crohn's disease	0.000104	0.00149	CcSEcCtD
Etoricoxib—Diarrhoea—Azathioprine—Crohn's disease	9.88e-05	0.00141	CcSEcCtD
Etoricoxib—Haemoglobin—Prednisone—Crohn's disease	9.85e-05	0.00141	CcSEcCtD
Etoricoxib—Haemorrhage—Prednisone—Crohn's disease	9.8e-05	0.0014	CcSEcCtD
Etoricoxib—Hallucination—Prednisone—Crohn's disease	9.75e-05	0.0014	CcSEcCtD
Etoricoxib—Hypersensitivity—Mesalazine—Crohn's disease	9.69e-05	0.00139	CcSEcCtD
Etoricoxib—Connective tissue disorder—Prednisone—Crohn's disease	9.63e-05	0.00138	CcSEcCtD
Etoricoxib—Dizziness—Azathioprine—Crohn's disease	9.55e-05	0.00137	CcSEcCtD
Etoricoxib—Asthenia—Mesalazine—Crohn's disease	9.44e-05	0.00135	CcSEcCtD
Etoricoxib—Pruritus—Mesalazine—Crohn's disease	9.31e-05	0.00133	CcSEcCtD
Etoricoxib—Vomiting—Azathioprine—Crohn's disease	9.18e-05	0.00131	CcSEcCtD
Etoricoxib—Eye disorder—Prednisone—Crohn's disease	9.16e-05	0.00131	CcSEcCtD
Etoricoxib—Rash—Azathioprine—Crohn's disease	9.11e-05	0.0013	CcSEcCtD
Etoricoxib—Dermatitis—Azathioprine—Crohn's disease	9.1e-05	0.0013	CcSEcCtD
Etoricoxib—Flushing—Prednisone—Crohn's disease	9.09e-05	0.0013	CcSEcCtD
Etoricoxib—Headache—Azathioprine—Crohn's disease	9.05e-05	0.00129	CcSEcCtD
Etoricoxib—Diarrhoea—Mesalazine—Crohn's disease	9e-05	0.00129	CcSEcCtD
Etoricoxib—Angiopathy—Prednisone—Crohn's disease	8.89e-05	0.00127	CcSEcCtD
Etoricoxib—Immune system disorder—Prednisone—Crohn's disease	8.85e-05	0.00127	CcSEcCtD
Etoricoxib—Arrhythmia—Prednisone—Crohn's disease	8.75e-05	0.00125	CcSEcCtD
Etoricoxib—Dizziness—Mesalazine—Crohn's disease	8.7e-05	0.00125	CcSEcCtD
Etoricoxib—Alopecia—Prednisone—Crohn's disease	8.66e-05	0.00124	CcSEcCtD
Etoricoxib—Mental disorder—Prednisone—Crohn's disease	8.58e-05	0.00123	CcSEcCtD
Etoricoxib—Nausea—Azathioprine—Crohn's disease	8.58e-05	0.00123	CcSEcCtD
Etoricoxib—Erythema—Prednisone—Crohn's disease	8.53e-05	0.00122	CcSEcCtD
Etoricoxib—Malnutrition—Prednisone—Crohn's disease	8.53e-05	0.00122	CcSEcCtD
Etoricoxib—Vomiting—Mesalazine—Crohn's disease	8.36e-05	0.0012	CcSEcCtD
Etoricoxib—Rash—Mesalazine—Crohn's disease	8.29e-05	0.00119	CcSEcCtD
Etoricoxib—Dermatitis—Mesalazine—Crohn's disease	8.29e-05	0.00119	CcSEcCtD
Etoricoxib—Headache—Mesalazine—Crohn's disease	8.24e-05	0.00118	CcSEcCtD
Etoricoxib—PTGS2—lymph node—Crohn's disease	8.18e-05	0.0116	CbGeAlD
Etoricoxib—Vision blurred—Prednisone—Crohn's disease	8.04e-05	0.00115	CcSEcCtD
Etoricoxib—Anaemia—Prednisone—Crohn's disease	7.88e-05	0.00113	CcSEcCtD
Etoricoxib—Agitation—Prednisone—Crohn's disease	7.84e-05	0.00112	CcSEcCtD
Etoricoxib—Nausea—Mesalazine—Crohn's disease	7.81e-05	0.00112	CcSEcCtD
Etoricoxib—Angioedema—Prednisone—Crohn's disease	7.79e-05	0.00112	CcSEcCtD
Etoricoxib—Hypertension—Prednisone—Crohn's disease	7.36e-05	0.00105	CcSEcCtD
Etoricoxib—Arthralgia—Prednisone—Crohn's disease	7.26e-05	0.00104	CcSEcCtD
Etoricoxib—Anxiety—Prednisone—Crohn's disease	7.24e-05	0.00104	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	7.21e-05	0.00103	CcSEcCtD
Etoricoxib—Oedema—Prednisone—Crohn's disease	6.96e-05	0.000996	CcSEcCtD
Etoricoxib—Anaphylactic shock—Prednisone—Crohn's disease	6.96e-05	0.000996	CcSEcCtD
Etoricoxib—Infection—Prednisone—Crohn's disease	6.91e-05	0.00099	CcSEcCtD
Etoricoxib—Shock—Prednisone—Crohn's disease	6.85e-05	0.00098	CcSEcCtD
Etoricoxib—Nervous system disorder—Prednisone—Crohn's disease	6.83e-05	0.000977	CcSEcCtD
Etoricoxib—Skin disorder—Prednisone—Crohn's disease	6.76e-05	0.000968	CcSEcCtD
Etoricoxib—Anorexia—Prednisone—Crohn's disease	6.63e-05	0.00095	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Prednisone—Crohn's disease	6.34e-05	0.000908	CcSEcCtD
Etoricoxib—Insomnia—Prednisone—Crohn's disease	6.29e-05	0.000901	CcSEcCtD
Etoricoxib—Dyspepsia—Prednisone—Crohn's disease	6.13e-05	0.000877	CcSEcCtD
Etoricoxib—Decreased appetite—Prednisone—Crohn's disease	6.05e-05	0.000866	CcSEcCtD
Etoricoxib—Fatigue—Prednisone—Crohn's disease	6e-05	0.000859	CcSEcCtD
Etoricoxib—Constipation—Prednisone—Crohn's disease	5.95e-05	0.000852	CcSEcCtD
Etoricoxib—Feeling abnormal—Prednisone—Crohn's disease	5.74e-05	0.000821	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Prednisone—Crohn's disease	5.69e-05	0.000815	CcSEcCtD
Etoricoxib—Urticaria—Prednisone—Crohn's disease	5.53e-05	0.000791	CcSEcCtD
Etoricoxib—Abdominal pain—Prednisone—Crohn's disease	5.5e-05	0.000787	CcSEcCtD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—TYK2—Crohn's disease	5.31e-05	0.00115	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—CXCL8—Crohn's disease	5.21e-05	0.00113	CbGpPWpGaD
Etoricoxib—Hypersensitivity—Prednisone—Crohn's disease	5.13e-05	0.000734	CcSEcCtD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—IL1B—Crohn's disease	5.12e-05	0.00111	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—JAK2—Crohn's disease	5.07e-05	0.00109	CbGpPWpGaD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—STAT3—Crohn's disease	5.01e-05	0.00108	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ICOSLG—Crohn's disease	5.01e-05	0.00108	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IL1B—Crohn's disease	5e-05	0.00108	CbGpPWpGaD
Etoricoxib—Asthenia—Prednisone—Crohn's disease	4.99e-05	0.000715	CcSEcCtD
Etoricoxib—Pruritus—Prednisone—Crohn's disease	4.92e-05	0.000705	CcSEcCtD
Etoricoxib—MAPK14—MAP kinase activation in TLR cascade—IL6—Crohn's disease	4.84e-05	0.00105	CbGpPWpGaD
Etoricoxib—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	4.8e-05	0.00104	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	4.8e-05	0.00104	CbGpPWpGaD
Etoricoxib—Diarrhoea—Prednisone—Crohn's disease	4.76e-05	0.000682	CcSEcCtD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—TYK2—Crohn's disease	4.73e-05	0.00102	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	4.69e-05	0.00101	CbGpPWpGaD
Etoricoxib—MAPK14—ATF-2 transcription factor network—IL6—Crohn's disease	4.64e-05	0.001	CbGpPWpGaD
Etoricoxib—Dizziness—Prednisone—Crohn's disease	4.6e-05	0.000659	CcSEcCtD
Etoricoxib—MAPK14—Innate Immune System—NOD1—Crohn's disease	4.56e-05	0.000985	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	4.53e-05	0.000978	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	4.52e-05	0.000977	CbGpPWpGaD
Etoricoxib—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	4.51e-05	0.000975	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—JAK2—Crohn's disease	4.51e-05	0.000975	CbGpPWpGaD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	4.49e-05	0.000969	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	4.47e-05	0.000966	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFNGR2—Crohn's disease	4.46e-05	0.000965	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—DEFA5—Crohn's disease	4.46e-05	0.000965	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—JAK2—Crohn's disease	4.44e-05	0.000958	CbGpPWpGaD
Etoricoxib—Vomiting—Prednisone—Crohn's disease	4.43e-05	0.000633	CcSEcCtD
Etoricoxib—Rash—Prednisone—Crohn's disease	4.39e-05	0.000628	CcSEcCtD
Etoricoxib—Dermatitis—Prednisone—Crohn's disease	4.38e-05	0.000628	CcSEcCtD
Etoricoxib—Headache—Prednisone—Crohn's disease	4.36e-05	0.000624	CcSEcCtD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—TNF—Crohn's disease	4.34e-05	0.000937	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	4.29e-05	0.000926	CbGpPWpGaD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	4.2e-05	0.000907	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—CXCL8—Crohn's disease	4.17e-05	0.0009	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CCR6—Crohn's disease	4.14e-05	0.000894	CbGpPWpGaD
Etoricoxib—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	4.14e-05	0.000893	CbGpPWpGaD
Etoricoxib—Nausea—Prednisone—Crohn's disease	4.13e-05	0.000592	CcSEcCtD
Etoricoxib—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	4.13e-05	0.000891	CbGpPWpGaD
Etoricoxib—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	4.12e-05	0.000889	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—JAK2—Crohn's disease	4.04e-05	0.000872	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL1B—Crohn's disease	4e-05	0.000863	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	3.92e-05	0.000847	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.87e-05	0.000836	CbGpPWpGaD
Etoricoxib—MAPK14—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—Crohn's disease	3.83e-05	0.000828	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—ZFP36L1—Crohn's disease	3.77e-05	0.000816	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	3.76e-05	0.000812	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—TNF—Crohn's disease	3.71e-05	0.000802	CbGpPWpGaD
Etoricoxib—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	3.71e-05	0.000801	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	3.68e-05	0.000795	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CARD9—Crohn's disease	3.64e-05	0.000786	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ACKR2—Crohn's disease	3.58e-05	0.000774	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—IL6—Crohn's disease	3.57e-05	0.000771	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—ITGA4—Crohn's disease	3.54e-05	0.000764	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.53e-05	0.000762	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.53e-05	0.000762	CbGpPWpGaD
Etoricoxib—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	3.52e-05	0.00076	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	3.5e-05	0.000756	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—TYK2—Crohn's disease	3.49e-05	0.000754	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88 cascade initiated on plasma membrane—IL6—Crohn's disease	3.47e-05	0.000749	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IL3—Crohn's disease	3.45e-05	0.000745	CbGpPWpGaD
Etoricoxib—MAPK14—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Crohn's disease	3.44e-05	0.000742	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—IL1B—Crohn's disease	3.43e-05	0.000742	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MLN—Crohn's disease	3.39e-05	0.000733	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—ALB—Crohn's disease	3.39e-05	0.000732	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88 dependent cascade initiated on endosome—IL6—Crohn's disease	3.37e-05	0.000729	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—RASGRP1—Crohn's disease	3.33e-05	0.00072	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—JAK2—Crohn's disease	3.33e-05	0.00072	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	3.33e-05	0.00072	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—IL6—Crohn's disease	3.31e-05	0.000716	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.3e-05	0.000714	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—CXCL8—Crohn's disease	3.3e-05	0.000713	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.29e-05	0.000711	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—UBE2D1—Crohn's disease	3.28e-05	0.000709	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	3.26e-05	0.000705	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—STAT3—Crohn's disease	3.26e-05	0.000704	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 9 (TLR9) Cascade—IL6—Crohn's disease	3.25e-05	0.000703	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—DNMT3A—Crohn's disease	3.21e-05	0.000693	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—IL6—Crohn's disease	3.2e-05	0.000691	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—RIPK2—Crohn's disease	3.18e-05	0.000688	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	3.15e-05	0.00068	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TAGAP—Crohn's disease	3.1e-05	0.000671	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88-independent cascade—IL6—Crohn's disease	3.07e-05	0.000663	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	3.03e-05	0.000655	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.01e-05	0.000651	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—RASGRP1—Crohn's disease	3e-05	0.000649	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3e-05	0.000648	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—IL6—Crohn's disease	3e-05	0.000648	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—STAT3—Crohn's disease	2.96e-05	0.00064	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—TAB1—Crohn's disease	2.94e-05	0.000635	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IL6—Crohn's disease	2.93e-05	0.000633	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	2.91e-05	0.000629	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—Crohn's disease	2.9e-05	0.000626	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—NOD2—Crohn's disease	2.89e-05	0.000623	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—IL6—Crohn's disease	2.88e-05	0.000623	CbGpPWpGaD
Etoricoxib—MAPK14—Activated TLR4 signalling—IL6—Crohn's disease	2.76e-05	0.000597	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by VEGF—IL6—Crohn's disease	2.72e-05	0.000588	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—SOCS1—Crohn's disease	2.72e-05	0.000588	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RSPO3—Crohn's disease	2.71e-05	0.000586	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—TYK2—Crohn's disease	2.69e-05	0.00058	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	2.67e-05	0.000577	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—SMAD3—Crohn's disease	2.66e-05	0.000574	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—NOD1—Crohn's disease	2.65e-05	0.000574	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—STAT3—Crohn's disease	2.65e-05	0.000573	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—IL6—Crohn's disease	2.6e-05	0.000561	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SEL1L—Crohn's disease	2.57e-05	0.000556	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.56e-05	0.000554	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.56e-05	0.000554	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—JAK2—Crohn's disease	2.56e-05	0.000554	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	2.54e-05	0.000549	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	2.54e-05	0.000549	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—CXCL8—Crohn's disease	2.49e-05	0.000539	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TNF—Crohn's disease	2.49e-05	0.000538	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—RSPO3—Crohn's disease	2.48e-05	0.000535	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—STAT3—Crohn's disease	2.45e-05	0.000528	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IL2RA—Crohn's disease	2.42e-05	0.000522	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CCR6—Crohn's disease	2.41e-05	0.000521	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.4e-05	0.000518	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PLA2G4F—Crohn's disease	2.37e-05	0.000512	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCR9—Crohn's disease	2.35e-05	0.000508	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SEL1L—Crohn's disease	2.35e-05	0.000507	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	2.34e-05	0.000505	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.34e-05	0.000505	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—IL6—Crohn's disease	2.31e-05	0.0005	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.25e-05	0.000486	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PLA2G4F—Crohn's disease	2.23e-05	0.000482	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PTPN2—Crohn's disease	2.2e-05	0.000476	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.19e-05	0.000473	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GPR65—Crohn's disease	2.19e-05	0.000473	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—RBX1—Crohn's disease	2.18e-05	0.000471	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—HSPA1B—Crohn's disease	2.17e-05	0.000468	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	2.15e-05	0.000466	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	2.11e-05	0.000456	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—LTF—Crohn's disease	2.11e-05	0.000455	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CRP—Crohn's disease	2.05e-05	0.000443	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—MTMR3—Crohn's disease	2.02e-05	0.000436	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—STAT3—Crohn's disease	2e-05	0.000433	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2e-05	0.000431	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—TLR4—Crohn's disease	1.97e-05	0.000425	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—UBE2D1—Crohn's disease	1.91e-05	0.000413	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—UBE2D1—Crohn's disease	1.9e-05	0.000411	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—MTMR3—Crohn's disease	1.9e-05	0.00041	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—STAT3—Crohn's disease	1.88e-05	0.000406	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.87e-05	0.000404	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ITGA4—Crohn's disease	1.85e-05	0.000401	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—RIPK2—Crohn's disease	1.85e-05	0.000401	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—IL6—Crohn's disease	1.85e-05	0.0004	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL3—Crohn's disease	1.81e-05	0.000391	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—RASGRP1—Crohn's disease	1.75e-05	0.000378	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—ALB—Crohn's disease	1.75e-05	0.000377	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD79A—Crohn's disease	1.74e-05	0.000377	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TYK2—Crohn's disease	1.73e-05	0.000375	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	1.72e-05	0.000372	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TAB1—Crohn's disease	1.71e-05	0.00037	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—Crohn's disease	1.71e-05	0.000369	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	1.7e-05	0.000368	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—GCKR—Crohn's disease	1.7e-05	0.000367	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—NOD2—Crohn's disease	1.68e-05	0.000363	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—JAK2—Crohn's disease	1.65e-05	0.000358	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—JAK2—Crohn's disease	1.62e-05	0.000351	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	1.58e-05	0.000342	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—SOCS1—Crohn's disease	1.58e-05	0.000342	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—FADS1—Crohn's disease	1.57e-05	0.000339	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	1.57e-05	0.000339	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCR6—Crohn's disease	1.56e-05	0.000337	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—TYK2—Crohn's disease	1.53e-05	0.000331	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SLC11A1—Crohn's disease	1.5e-05	0.000324	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—FADS1—Crohn's disease	1.48e-05	0.00032	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GPX4—Crohn's disease	1.47e-05	0.000318	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MTMR3—Crohn's disease	1.46e-05	0.000316	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—JAK2—Crohn's disease	1.46e-05	0.000316	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.44e-05	0.00031	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL18—Crohn's disease	1.43e-05	0.000308	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GCKR—Crohn's disease	1.42e-05	0.000307	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RBX1—Crohn's disease	1.41e-05	0.000305	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—IL6—Crohn's disease	1.4e-05	0.000303	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD4—Crohn's disease	1.39e-05	0.000299	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GPX4—Crohn's disease	1.39e-05	0.000299	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PTGER4—Crohn's disease	1.37e-05	0.000296	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—SMAD3—Crohn's disease	1.36e-05	0.000294	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MTMR3—Crohn's disease	1.35e-05	0.000291	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	1.34e-05	0.00029	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GCKR—Crohn's disease	1.34e-05	0.000289	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MTMR3—Crohn's disease	1.34e-05	0.000289	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—IL6—Crohn's disease	1.31e-05	0.000284	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—RBX1—Crohn's disease	1.29e-05	0.000278	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HSPA1B—Crohn's disease	1.29e-05	0.000278	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL2RA—Crohn's disease	1.27e-05	0.000274	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—UBE2D1—Crohn's disease	1.24e-05	0.000267	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—STAT3—Crohn's disease	1.21e-05	0.000262	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RIPK2—Crohn's disease	1.2e-05	0.000259	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CRP—Crohn's disease	1.19e-05	0.000258	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL3—Crohn's disease	1.17e-05	0.000253	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TLR4—Crohn's disease	1.15e-05	0.000247	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MTMR3—Crohn's disease	1.14e-05	0.000247	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—FADS1—Crohn's disease	1.14e-05	0.000247	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RASGRP1—Crohn's disease	1.13e-05	0.000244	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—UBE2D1—Crohn's disease	1.13e-05	0.000244	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ICAM1—Crohn's disease	1.1e-05	0.000237	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GPX4—Crohn's disease	1.07e-05	0.000231	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TNF—Crohn's disease	1.05e-05	0.000227	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—FADS1—Crohn's disease	1.05e-05	0.000227	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—FADS1—Crohn's disease	1.04e-05	0.000225	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	1.04e-05	0.000224	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GCKR—Crohn's disease	1.03e-05	0.000223	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SOCS1—Crohn's disease	1.02e-05	0.000221	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.02e-05	0.000219	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GPX4—Crohn's disease	9.83e-06	0.000212	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GPX4—Crohn's disease	9.74e-06	0.000211	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GCKR—Crohn's disease	9.49e-06	0.000205	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GCKR—Crohn's disease	9.41e-06	0.000203	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TYK2—Crohn's disease	8.92e-06	0.000193	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—FADS1—Crohn's disease	8.89e-06	0.000192	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SMAD3—Crohn's disease	8.84e-06	0.000191	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MTMR3—Crohn's disease	8.81e-06	0.00019	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—JAK2—Crohn's disease	8.51e-06	0.000184	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—IL6—Crohn's disease	8.48e-06	0.000183	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFNG—Crohn's disease	8.35e-06	0.000181	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GPX4—Crohn's disease	8.33e-06	0.00018	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL2RA—Crohn's disease	8.19e-06	0.000177	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD4—Crohn's disease	8.07e-06	0.000174	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SMAD3—Crohn's disease	8.07e-06	0.000174	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GCKR—Crohn's disease	8.04e-06	0.000174	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IL6—Crohn's disease	7.49e-06	0.000162	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1B—Crohn's disease	7.45e-06	0.000161	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	7.38e-06	0.000159	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—FADS1—Crohn's disease	6.86e-06	0.000148	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.73e-06	0.000145	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.45e-06	0.000139	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GPX4—Crohn's disease	6.43e-06	0.000139	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—STAT3—Crohn's disease	6.25e-06	0.000135	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GCKR—Crohn's disease	6.21e-06	0.000134	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.88e-06	0.000127	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TYK2—Crohn's disease	5.77e-06	0.000125	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.75e-06	0.000124	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—JAK2—Crohn's disease	5.5e-06	0.000119	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TYK2—Crohn's disease	5.26e-06	0.000114	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.03e-06	0.000109	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL8—Crohn's disease	5.02e-06	0.000109	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—JAK2—Crohn's disease	5.02e-06	0.000108	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD4—Crohn's disease	4.76e-06	0.000103	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ALB—Crohn's disease	4.52e-06	9.77e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—Crohn's disease	4.36e-06	9.43e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ALB—Crohn's disease	4.26e-06	9.2e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—STAT3—Crohn's disease	4.04e-06	8.73e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS2—Crohn's disease	3.72e-06	8.05e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—STAT3—Crohn's disease	3.68e-06	7.96e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ALB—Crohn's disease	3.28e-06	7.1e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ALB—Crohn's disease	3.02e-06	6.53e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ALB—Crohn's disease	2.99e-06	6.47e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS2—Crohn's disease	2.87e-06	6.21e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—Crohn's disease	2.82e-06	6.1e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS2—Crohn's disease	2.64e-06	5.71e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS2—Crohn's disease	2.62e-06	5.66e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—Crohn's disease	2.57e-06	5.56e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALB—Crohn's disease	2.56e-06	5.53e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS2—Crohn's disease	2.24e-06	4.84e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALB—Crohn's disease	1.98e-06	4.27e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.73e-06	3.73e-05	CbGpPWpGaD
